Alibaba Health Information Technology Limited (HKG: 0241)

Market Cap	46.64B
Revenue (ttm)	29.29B
Net Income (ttm)	957.56M
Shares Out	16.08B
EPS (ttm)	0.07
PE Ratio	42.67
Forward PE	25.22
Dividend	n/a
Ex-Dividend Date	n/a

Volume	24,562,709
Open	2.870
Previous Close	2.900
Day's Range	2.860 - 2.920
52-Week Range	2.590 - 5.080
Beta	1.02
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 11, 2024

About Alibaba Health Information Technology

Alibaba Health Information Technology Limited, an investment holding company, engages in the pharmaceutical direct sales, pharmaceutical e-commerce platform, and healthcare and digital services businesses in Mainland China and Hong Kong. The company offers a range of prescription and over-the-counter drugs, nutritional supplements, medical devices, contact lenses, health food, adult and family planning products, healthcare and skincare products, and various other health-related products. It also provides medical and healthcare services, includi...

• Industry: Pharmaceutical Retailers
• Sector: Healthcare
• Founded: 1998
• Employees: 1,435
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 0241

Financial Performance

In 2023, Alibaba Health Information Technology's revenue was 27.03 billion, an increase of 0.98% compared to the previous year's 26.76 billion. Earnings were 883.48 million, an increase of 64.93%.

Financial numbers in CNY